Current Press Releases:
December 18, 2007 - Phylonix Granted Broad European Patent for Transplanting Human Cells Into Zebrafish
October 2, 2007 - NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Models for Eye Diseases
April 12, 2007 - EPA Selects Phylonix to Screen Compound Library in Zebrafish
December 12, 2006 - Phylonix Awarded National Science Foundation Phase II SBIR to Screen Industrial Chemicals for Effects on Developmental Toxicity in Zebrafish
August 8, 2006 - Zebrafish Show Advantages in Assessing Human Cancer Cell-Induced Angiogenesis In Vivo
May 10, 2006 - Phylonix Issued Broad U.S. Patent for Screening Angiogenic Compounds using Zebrafish
Archived Press Releases:
June 2, 2004 - NIH Awards Phylonix Phase II SBIR to Develop Zebrafish Apoptosis Drug Screening Assays
March 30, 2004 - Phylonix Granted U.S. Patent for High Throughput Drug Screening Using Zebrafish
|